Ross Irvine, corporate activist and president of ePublic Relations, points out how business PR can learn from anti-biotech activists and NGOs. Irvine recommends taking a broader view of the issue, going beyond traditional allies and PR activities. According to Irvine, "With creative thinking a great deal of synergy among biotech and other issues is possible and essential."